Concepedia

Charles Chesnelong

CC

Statistics

Publications

11

Citations

999

H-Index

11

Active since

2011

Affiliations

University of Calgary(Current)

Hotchkiss Brain Institute

Foothills Medical Centre

University of British Columbia

Hospital for Sick Children

Charles Chesnelong is an author at University of Calgary specializing in oncology, medicine, and cancer stem cells.

Publications per year

2011–2021

11

Publications

11

Concurrent <i>CIC</i> mutations, <i>IDH</i> mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers

Stephen Yip, Yaron S.N. Butterfield, Olena Morozova et al. · The Journal of Pathology · 2011 · 310 citations · Full text

Medicine, Genetics, Oncology +16

Lactate dehydrogenase A silencing in IDH mutant gliomas

Charles Chesnelong, Myriam M. Chaumeil, Michael Blough et al. · Neuro-Oncology · 2013 · 215 citations · Full text

Medicine, Cancer Biology, Oncology +17

Clonal expansion and epigenetic reprogramming following deletion or amplification of mutant <i>IDH1</i>

Tali Mazor, Charles Chesnelong, Aleksandr Pankov et al. · Proceedings of the National Academy of Sciences · 2017 · 140 citations · Full text

Medicine, Genetics, Oncology +15

Single-cell chromatin accessibility profiling of glioblastoma identifies an invasive cancer stem cell population associated with lower survival

Paul Guilhamon, Charles Chesnelong, Michelle Kushida et al. · eLife · 2021 · 97 citations · Full text

Medicine, Cell Biology, Oncology +17

Hyperpolarized 13C MR imaging detects no lactate production in mutant IDH1 gliomas: Implications for diagnosis and response monitoring

Myriam M. Chaumeil, Marina Radoul, Chloé Najac et al. · NeuroImage Clinical · 2016 · 67 citations · Full text

Medicine, Neuroscience, Oncology +17

1–5 of 11